The Maker Of Marlboro Cigarettes Is Gaining A 'unique Entry Into Cannabis' (mo, Cron)

AP Altria's $1.8 billion investment in the cannabis producer Cronos is mutually beneficial, a Cowen analyst says. Cronos has a focus on rare cannabinoids, which has greater potential than just focusing on the two most known cannabinoids, Azer added. Cronos can leverage Altria's expertise to focus on ingredient composition without reliance on a massive cultivation infrastructure, Azer said. Watch Altria and Cronos trade live. Marlboro cigarette maker Altria's $1.8 billion investment in the cannabis producer Cronos is a win-win, according to an analyst. "Cronos provides Altria a unique entry into cannabis and we do not think Altria is taking on outsized risk while entering a new high-growth category," Vivien Azer, an analyst at Cowen, said in a note out on Monday.See the rest of the story at Business InsiderNOW WATCH: 7 things you shouldn't buy on Black FridaySee Also:Theresa May delays Brexit-deal vote to avoid huge defeat in ParliamentScience says people decide these 11 things within seconds of meeting youShare your opinion — become a BI Insider!